Multiple interactions of complement Factor H with its ligands in solution: a progress report.
Factor H (FH) is the major regulator of the central complement protein C3b in the alternative pathway of complement activation, and is comprised of 20 SCR domains. A FH Tyr402His polymorphism in SCR-7 is associated with age-related macular degeneration (AMD) and leads to deposition of complement in drusen. The unravelling of how FH interacts with five major physiological and patho-physiological ligands is complicated by the weak nature of these interactions, coupled with the multivalency of FH. Using multiple biophysical methods, we summarise our recent results for these five FH ligands: (1) FH by itself shows a folded-back SCR domain structure in solution, and self-associates in a manner dependent on electrostatic forces. (2) FH activity is inhibited by zinc, which causes FH to aggregate. The onset of FH-zinc aggregation for zinc concentrations above 20 muM appears to be enhanced with the His402 allotype, and may be relevant to AMD. (3) The FH and C-reactive protein (CRP) interaction has been controversial; however our new work resolves earlier discrepancies. The FH-CRP interaction is only observed when native CRP is at high acute-phase concentration levels, and CRP binds weakly to the His402 FH allotype to suggest a molecular mechanism that leads to AMD. (4) Heparin is an analogue of the polyanionic host cell surface, and FH forms higher oligomers with larger heparin fragments, suggesting a mechanism for more effective FH regulation. (5) The interaction of C3b with FH also depends on buffer, and FH forms multimers with the C3d fragment of C3b. This FH-C3d interaction at high FH concentration may also facilitate complement regulation. Overall, our results to date suggest that the FH interactions involving zinc and native CRP have the closest relevance for explaining the onset of AMD.
Perkins
Stephen J
SJ
Department of Structural and Molecular Biology, University College London, London, UK. s.perkins@medsch.ucl.ac.uk
Nan
Ruodan
R
Okemefuna
Azubuike I
AI
Li
Keying
K
Khan
Sanaullah
S
Miller
Ami
A
D055592:Biophysical Phenomena; D002097:C-Reactive Protein / Q000737:chemistry / Q000378:metabolism; D015933:Complement C3d / Q000737:chemistry / Q000378:metabolism; D017242:Complement Factor H / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D006493:Heparin / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008024:Ligands; D008268:Macular Degeneration / Q000209:etiology / Q000235:genetics / Q000276:immunology; D008958:Models, Molecular; D046912:Multiprotein Complexes; D055503:Protein Multimerization; D017434:Protein Structure, Tertiary; D012996:Solutions; D015032:Zinc / Q000737:chemistry / Q000378:metabolism
D008024:Ligands; D046912:Multiprotein Complexes; D012996:Solutions; D015933:Complement C3d; D017242:Complement Factor H; D006493:Heparin; D002097:C-Reactive Protein; D015032:Zinc